Product Details
EA/1
$ *.**
In Stock
$ *.**
Additional Information
| Product Name | Kevzara (sarilumab) Injection, 175.4 mg/mL, 1.14 mL Prefilled Pen, Box of 2 Prefilled Pens |
| Manufacturer | -- |
| Generic/Active Ingredient | Sarilumab |
| Route of Administration | Subcutaneous |
| Dose Form | Parenteral preparations |
| Strength | 175.4 mg / 1 mL |
| Container Type | Box |
| Volume | 1.14 mL |
| Mechanism of Action | Sarilumab blocks interleukin-6 receptors, which reduces IL-6 signaling. |
| Application | IL-6 Receptor Antagonist |
| Side Effects | Adverse events include infection, neutropenia, thrombocytopenia, elevated liver enzymes, injection site reactions, hypersensitivity, lipid increases, gastrointestinal perforation, fatigue, and myalgia. |
| Storage | Discard product if it contains particulate matter, is cloudy, or discolored. Discard unused portion. Do not store for later use. Do not expose product to temperatures above 77°F. Do not freeze. For best results, product should be at room temperature before use. Product must be used within 14 days after removal from refrigeration to room temperature (77°F). Refrigerate at 36°F to 46°F. Store in the original carton to protect from light. |
This description is for informational purposes only and is not clinical advice.
Frequently Asked Questions (FAQs)
The cost of KEVZARA SY 200MG/1.14ML 2X1.14PEN is $$0.00
KEVZARA SY 200MG/1.14ML 2X1.14PEN is manufactured by --.
You can purchase KEVZARA SY 200MG/1.14ML 2X1.14PEN on our website at https://pharmacyhub.pipelinemedical.com/product/detail/kevzara-sy-200mg-1-14ml-2x1-14pen-640831